# Evaluation of Centralised TB Assay Solutions

> **NCT04147676** · — · COMPLETED · sponsor: **Foundation for Innovative New Diagnostics, Switzerland** · enrollment: 1050 (actual)

## Conditions studied

- Tuberculosis
- Drug-resistant Tuberculosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04147676
- **Lead sponsor:** Foundation for Innovative New Diagnostics, Switzerland
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-20
- **Primary completion:** 2023-04-17
- **Final completion:** 2023-09-01
- **Target enrollment:** 1050 (ACTUAL)
- **Last updated:** 2023-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04147676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04147676, "Evaluation of Centralised TB Assay Solutions". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04147676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*